Compare iShares Core MSCI Emerging Markets ETF (IEMG) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI Emerging Markets ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? iShares Core MSCI Emerging Markets ETF trades at $81.25 (market cap $162.00B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.96 (market cap $25.27B). The key difference: iShares Core MSCI Emerging Markets ETF is far larger — about 6.4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares Core MSCI Emerging Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI Emerging Markets ETF for 57 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| IEMG | RPRX | |
|---|---|---|
Market Cap | $162.00B | $25.27B |
Volume | 13,446,151 | 3,671,183 |
Sector | Broad Market / Factor | Health |
52-Week High | $86.00 | $63.96 |
52-Week Low | $64.22 | $35.44 |
Typical Hold Time | 57 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEMG trades at $81.14, down 1.1% with a bearish technical signal from moving averages. The ETF's emerging markets focus has delivered strong recent performance, with articles highlighting 35% one-year returns and record asset inflows. Technical indicators show neutral oscillators but bearish momentum, with key support at $79 and resistance at $82.
Emerging markets exposure offers growth potential amid dollar weakness, though higher volatility and expense ratios compared to developed market ETFs present risks. The fund's 39% technology weighting and outperformance versus peers like SCHE and VWO provide differentiation, but concentration risks and market sensitivity require careful monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
